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Abstract The role of human dendritic cells (DC) in the
immune response toward intracellularly growing Listeria
was analyzed under in vitro conditions using several
morphological and functional methods. DC incubated
with Listeria innocua and L. monocytogenes, respec-
tively, readily phagocytosed the bacteria. Listeria did
not impair viability and immunogenic potential of hu-
man DC. Listerial antigens were found to be processed
within the lysosomal compartment of DC and colocal-
ized with major histocompatibility complex (MHC) class
II molecules, as shown by ﬂuorescence and transmission
electron microscopy. DC challenged with apathogenic
L. innocua were highly eﬀective in priming autologous
naı¨ve T cells (mainly CD4+) in vitro. The T cells
strongly proliferated in the presence of DC incubated
with L. innocua, which could be signiﬁcantly inhibited by
anti-MHC II mAb. L. innocua-primed T cells were also
successfully stimulated by DC harboring the pathogenic
L. monocytogenes, either the wild-type strain EGD or
the p60 reduced mutant strain RIII. From our results,
we conclude that human DC infected with nonpatho-
genic intracellular bacteria are able to eﬃciently prime
naı¨ve T cells, which are then suitable for recognition of
antigens derived from related virulent bacterial species.
This in vitro human model provides an interesting tool
for basic research in infectious immunology and possibly
for a new immunotherapy.
Keywords Antigen processing Æ Antigen presentation Æ
Dendritic cells Æ Listeria innocua Æ
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Introduction
Listeria monocytogenes are gram-positive, facultative
intracellular bacteria. They may cause gastrointestinal
disease after ingestion via contaminated food. L. mon-
ocytogenes can enter cells via internalin A- and B-med-
iated phagocytosis. In order to avoid the bactericidal
eﬀect of phagolysosomal fusion, Listeria disrupt the
phagosomal membrane using listeriolysin and phos-
pholipases and escape into the cytosol where they can
replicate. By actin-based motility, Listeria spread from
cell to cell (Cabanes et al. 2002; Cossart and Bierne 2001;
Portnoy et al. 2002).
In a rat intestinal loop system, dendritic cells (DC)
were identiﬁed as ﬁrst cellular targets of infection with
L. monocytogenes and found to be critically involved in
subsequent transportation of the pathogen to the lymph
nodes (Pron et al. 2001). DC are the most potent anti-
gen-presenting cells and are crucial for the initiation of a
speciﬁc T cell response against infectious agents. They
are derived from CD34+ bone marrow cells that mi-
grate, through the blood circulation, to most organs and
tissues where they become immature DC. The immature
DC are able to phagocytose and process antigens,
including bacteria. Mature DC present antigens on the
major histocompatibility complex (MHC) class I and II
molecules to naı¨ve T cells, and they induce a speciﬁc
cellular immune response (Banchereau and Steinman
1998; Kapsenberg 2003).
Human DC are known to phagocytose L. monocyt-
ogenes and to subsequently mature (Paschen et al. 2000;
Kolb-Ma¨urer et al. 2000, 2001, 2003a). It has been found
that opsonization of L. monocytogenes with human
serum signiﬁcantly enhances phagocytosis of the DC via
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FccRIII (CD16)-mediated receptor uptake. The pre-
dominant opsonins seem to be antibodies (Abs) directed
against the p60 protein, which is constitutively expressed
also in the apathogenic L. innocua. This apathogenic
Listeria species is ubiquitously present in our environ-
ment, especially in nutrition. Anti-p60 protein Abs in-
duced by environmental challenge with L. innocua are
postulated to bind L. monocytogenes also and thus en-
hance phagocytosis by the DC. This indicates a link
between humoral and cellular immunity that could
provide an important barrier against the spread of vir-
ulent L. monocytogenes via the blood stream, which may
contribute to the generally low morbidity rates of liste-
riosis (Kolb-Ma¨urer et al. 2001).
In mice, the potential role of L. innocua for
enhancement of L. monocytogenes p60-speciﬁc CD4+
and CD8+ T-cell memory has been demonstrated
(Harty and Pamer 1995; Geginat et al. 1999; Sˇkoberne
and Geginat 2002). The intracellular fate of L. mono-
cytogenes has also been investigated in many studies
carried out in animal models (Vasquez-Boland et al.
2001; Portnoy et al. 2002; Park et al. 2004).
On the contrary, only few data exist on the cellular
immune reaction to Listeria in humans (Bla¨uer et al.
1995; Guo et al. 1995; Paschen et al. 2000; Kolb-Ma¨urer
et al. 2000, 2001, 2003a, 2003b; Neumann et al. 2003).
Little is known about antigen presentation of Listeria-
challenged DC to T lymphocytes. Especially, links be-
tween the environmental challenge with the apathogenic
L. innocua and induction of a cellular cross-reactive
immune response toward L. monocytogenes has not been
demonstrated in humans to date. It is unknown whether
human T cells can be primed by DC infected with the
avirulent L. innocua and whether these T cells are
capable of mounting an eﬃcient cross-reacting response
toward pathogenic L. monocytogenes. This approach
could be of interest for a better understanding of the
cellular immune response in listeriosis.
Even though severe listeriosis is rare, in immunocom-
promised patients, it may cause sepsis, encephalitis, and
meningitis. Infected pregnant women may suﬀer from
chorioamnitis, which usually leads to abortion (Vasquez-
Boland et al. 2001). Very rarely, L. monocytogenes causes
endogenous endophthalmitis, which demands surgical
intervention and, in prolonged cases, might even lead to
visual loss (Berger et al. 2004). To date, the recovery rate
of listeriosis by antibiotics is only approximately 70%
(Hof 2004). One reason seems to be that antibiotics only
poorly penetrate the cerebrospinal ﬂuid and thus only
high doses over a long period are curative. Furthermore,
the intracellular localization of Listeria impairs the access
to antibiotics. Immunomodulation to reconstitute im-
mune defense capacity could presumably help to improve
these conditions (Hof 2004).
This in vitro study was intended to characterize
antigen presentation by human DC infected with both
L. innocua and L. monocytogenes. First, we tested the
uptake and inﬂuence of various Listeria species on DC
function. Second, we investigated the antigen processing
and presentation by the DC and intracellular fate of the
Listeria. The third part dealt with the generation of
speciﬁc T cells using autologous DC infected with
L. innocua and testing their speciﬁcity on the pathogenic
L. monocytogenes. We also analyzed potential antigens
for cross-reactivity using a wild-type L. monocytogenes
strain (EGD) and a p60-reduced rough mutant strain
(RIII) and L. innocua, which are naturally lacking all
PrfA-regulated virulence factors, including listeriolysin.
Materials and methods
Generation of DC
Human DC were generated in vitro from blood-derived
precursors, as already described (Filgueira et al. 1996).
Brieﬂy, human peripheral blood mononuclear cells
(PBMC) obtained from venous blood of healthy donors
(Blood Bank SRK, Zu¨rich, Switzerland) were isolated
by Ficoll-Paque (Pharmacia Biotech, Uppsala, Sweden)
density centrifugation. The PBMC were cultured in
RPMI 1640 supplemented with penicillin/streptomycin
(All Life Technologies, Paisley, UK) and 10% heat-
inactivated pooled human A serum (Blood Bank SRK)
for 2 h. The adherent cells were further cultured in
RPMI 1640 containing 5% heat-inactivated pooled hu-
man A serum, recombinant human granulocyte mono-
cyte colony-stimulating factor (rhGM-CSF, 50 ng/ml,
Novartis, Basel, Switzerland), and interleukin-4 (rhIL-4,
100 U/ml, R&D Systems, Abingdon, UK) for 6 days.
Infection of DC with Listeria
Listeria species and strains (see Table 1) were stored as 1-
ml aliquots at 80C. For experiments, a single aliquot
was propagated in 50 ml of tryptic soy broth (Difco
Laboratories, Detroit, MI, USA) at 37Cwith aeration in
a shaker incubator at 300 rpm for 16 h (Bla¨uer et al.
1995). DC were infected with Listeria opsonized for
30 min at 37C in a mixture of 50%RPMI 1640 and 50%
pooled heat-inactivated human A serum. For challenge,
108 bacteria were added to 5·105DC, giving amultiplicity
of infection (MOI) of 200 bacteria per DC (six-well tissue
culture plates, Costar, NY, USA). After 30 min of co-
incubation, the cell culture was washed with phosphate-
buﬀered saline (PBS) and incubated overnight in culture
medium supplemented with 100 lg/ml of gentamicin
(Sigma, Buchs, Switzerland). The following day, DCwere
rinsed with PBS and resuspended in culture medium
containing 50 lg/ml of gentamicin before use for the
diﬀerent experiments.
The viability and immunogenic potential of DC
The viability of DC after infection with the diﬀerent
Listeria species and strains was examined by a ﬂuores-
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cence release assay (Vollenweider et al. 1994). In brief,
DC were infected, in 96-well ﬂat bottom plates (Nunc,
Roskilde, Denmark), with the Listeria, incubated over-
night with gentamicin, as already described and the next
day labelled with BCECF/AM (5 lg/ml, Nova Biochem,
Lucerne, Switzerland) for 2 h. Unchallenged DC served
as low control and triton-lysed DC as high control. The
ﬂuorochrome release from live DC was detected with
Cytoﬂuor 2300 (Millipore, Volketswil, Switzerland) and
the viability calculated by the formula:
Percentage of living DC = (experimental value –
triton-lysed DC)/(untreated DC – triton-lysed DC)·100.
In order to evaluate the inﬂuence of Listeria infection
on DC surface marker expression, DC were tested by
ﬂow cytometry (Becton-Dickinson, San Jose`, CA,
USA). Fluorochrome-conjugated monoclonal antibod-
ies (mAbs) directed against human CD80, CD83, and
MHC II (HLA-DR, DP, and DQ, all PharMingen,
Basel, Switzerland), CD14 (Diatec, Oslo, Norway), and
CD16 (Becton-Dickinson) were used. A mouse anti-c1
Ab (Becton-Dickinson) served as isotype control. For
CD86 staining, we used an mAb purchased from Serotec
Ltd. (Kidlington, Oxford, UK) followed by an FITC-
labeled polyclonal goat anti-mouse Ab (Kirkegard &
Perry Laboratory, Gaithersburg, MD, USA). All Abs
were incubated at 4C for 15 min (dilution 1:50).
Fluorescence microscopy
The adherent DC were ﬁxed in six-well tissue culture
plates with 3% paraformaldehyde and 2% sucrose in
PBS, scraped with a cell scraper (Costar), and spun onto
glass slides. Permeabilization was performed by placing
in a microwave for 10 min at 900 W in 150 ml PBS.
Thereafter, PBS containing 0.1% bovine serum albumin
and 2% normal goat serum was used as blocking-buﬀer
solution. Nuclear and bacterial DNA were stained with
DAPI (4,6-diamidine-2-phenyl-indol-dihydrochlorid,
5 lg, Roche, Mannheim, Germany). Listeria were de-
tected with a polyclonal anti-Listeria Ab (Fehr et al.
1997) kindly provided by Dr. Bille (WHO Collaborative
Center for Foodborne Listeriosis, Centre Hospitalier
Universitaire Vaudois, Lausanne, Switzerland). A Texas
red conjugated polyclonal goat anti-rabbit Ab (Jackson
Immuno Research Laboratories, West Grove, PA, USA)
was used as secondary Ab. For double immunoﬂuores-
cence, the phagolysosomes of the DC were stained with a
mouse mAb directed against the lysosomal-associated
membrane protein LAMP-1 (CD107a, PharMingen), a
late phagosome maturation marker (Chang et al. 2002;
de Saint-Vis et al. 1998). In another double-immunoﬂu-
orescence protocol, the MHC II molecules were visual-
ized by an mAb directed against human MHC II
(HLA-DR, DP, and DQ; PharMingen). For detection of
intracellular MHC II colocalized with Listeria, we used a
microwave, as already described. For simultaneous
staining of membrane-bound MHC II with intracellular
Listeria, we performed cell permeabilization by Triton
X100 treatment (1% in PBS, 40 s, room temperature)
because with this procedure, the membrane-boundMHC
II molecules remained intact. Mouse mAb addition was
followed by a polyclonal biotin-coupled sheep anti-
mouse Ab (Amersham Pharmacia Biotech, Du¨bendorf,
Switzerland) and FITC-labeled streptavidine (Bio-Sci-
ence, Emmenbru¨cke, Switzerland). All Abs and reagents
for staining were diluted to a previously tested optimal
concentration in blocking-buﬀer solution. Exclusion of
the primary Abs and noninfected DC served as negative
controls. The specimens were analyzed as 0.2-lm-thin
optical sections with a confocal laser-scanning micro-
scope (CLSM, Leica, Heidelberg, Germany) using the
Imaris software (Bitplane AG, Zu¨rich, Switzerland).
Transmission electron microscopy
Listeria-harboring DC were preﬁxed in 0.1 M cacody-
late buﬀer containing 2.5% glutaraldehyde and 0.8%
paraformaldehyde, scraped, postﬁxed with an aqeuous
solution of 1% OsO4 and 1.5% K4Fe(CN)6, and
embedded into epon. Transmission electron microscopy
(TEM) analysis of ultrathin (approximately 50 nm)
sections contrasted with lead citrate and uranyl acetate
was performed with a CM 100 (Philips, Eindhoven, The
Netherlands).
Generation and characterization of Listeria-speciﬁc
T lymphocytes
For generating Listeria-speciﬁc T cells, we co-incubated
in-vitro-generated DC from three healthy donors with
L. innocua. Brieﬂy, DC were infected with L. innocua at
MOI of 200 for 30 min, rinsed, and cultured overnight
with gentamicin to kill extracellular bacteria. The
following day, freshly isolated nonadherent autologous
Table 1 Listeria species and strains used
Strain Genotype Virulence factors/regulation Reference
Listeria monocytogenes
EGD Wild-type All virulence factors/PrfA P60/iap Schaﬀner 1985
RIII p60 Mutant All virulence factors/PrfA p60 greatly reduced Bubert et al. 1992
Listeria innocua
LL-263 Wild-type No virulence factors P60/iap Bille and Rocourt 1996
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PBMC (5·106/ml) were added to the DC (105/ml in
six-well plates). PBMC were cultured in RPMI 1640
containing 5% pooled human A serum and antibiotics
under weekly restimulation. No additional cytokines
were used for the ﬁrst 3 weeks. After 3 weeks, 100 U/ml
rhIL-2 (R&D Systems) were added. Cytoﬂuorometry of
the T lymphocytes was performed using FITC-labeled
anti-human CD4, PE-coupled anti-human CD8 (both
Serotec Ltd.), FITC-labeled anti-human CD3, PE-cou-
pled anti-human CD16, and anti-human CD56 (all
Becton-Dickinson) Abs on day 0 and after 2 weeks and
3 weeks in culture.
Speciﬁcity assays
Speciﬁcity of the T lymphocytes primed by use of
autologous DC was tested after 3 weeks of stimulation
in proliferation assays, as already described (Filgueira
et al. 1996). Brieﬂy, proliferative response of the T cells
was measured by application of a 12-h pulse with 63H-
thymidine (0.5 mCi/well, speciﬁc activity 20 Ci/mmol,
Amersham Pharmacia Biotech). Autologous DC either
loaded with inactivated (gentamicin or heat) L. mono-
cytogenes or with vital L. innocua were washed and co-
cultured for 3 days with the Listeria-speciﬁc T cells (in
triplicates, 105 T cells and 104 DC per well, 96-well
round bottom plates, Nunc). Thereafter, cells were
harvested with the LKB harvesting system using glass
ﬁber ﬁlter mats, and the incorporated 63H-thymidine
was detected using the beta-plate liquid scintillation
counting system (all components LKB, Wallac Oy,
Turku, Finland).
To analyze antigen presentation on MHC II mole-
cules of the virulent species also, the escape of L. mon-
ocytogenes from the DC phagosomes was suppressed by
treatment with gentamicin (300 lg/ml) prior to infec-
tion. Successful deactivation of the Listeria was assured
in an overnight culture in 50 ml of tryptic soy broth
where untreated L. monocytogenes could be successfully
propagated. Cocultivation of the Listeria-speciﬁc T cells
with untreated DC and of naı¨ve PBMC with Listeria-
infected DC served as negative controls. For positive
control, T cells were cocultured with untreated DC in
the presence of anti-CD3 mAb (clone CB3G) at maximal
stimulatory concentration as nonspeciﬁc mitogenic
stimulus (Filgueira et al. 1993). Furthermore, for
blocking MHC class II antigen presentation, we used the
mAbs directed against human MHC II (HLA-DR, DP,
and DQ, PharMingen).
Statistical analysis
All results are expressed as mean ± standard deviation.
Statistical analysis of the data was performed with a
StatView program (Abacus Concepts Inc., Berkeley,
CA, USA). This included an analysis of variance (Bon-
ferroni/Dunn) with the signiﬁcance level of P<0.01.
Results
The viability and immunogenic potential of human DC
after uptake of Listeria
In the ﬁrst step, uptake of live Listeria species L. innocua
and L. monocytogenes by human DC and intracellular
localization were visualized by TEM. We found the al-
ready described zipper-like uptake for both Listeria
species (compare Kolb-Ma¨urer et al. 2000) by the DC
generated with our culture protocol (Fig. 1). Bacteria of
both the tested strains (EGD and RIII) of L. monocyt-
ogenes were found free in the cytosol as well as within
the vacuoles of DC. The p60-reduced strain RIII dis-
played the typical chain formation, indicating disturbed
cell division, as already described (Minkowski et al.
2001). Furthermore, bacteria of all the Listeria species
and strains investigated were found, by TEM, disrupted
within phagolysosomes of the DC (data not shown).
Thus, we were assured that DC generated with our
culture protocol were capable of suﬃcient uptake of the
Listeria at MOI of 200.
Secondly, we wanted to ascertain that DC challenged
with Listeria were not functionally impaired in their
viability and immunogenic potential. For that pur-
pose, DC viability was tested 16 h after challenge with
L. innocua and L. monocytogenes strain EGD by a
ﬂuorochrome release assay at MOI of 200 (Fig. 2a).
Data were consistent with the results obtained by LDH
release and MTT assays (data not shown). In all tests
applied, Listeria-challenged DC revealed a high
percentage of live cells.
In addition, the inﬂuence of Listeria uptake on DC
maturation was assessed by ﬂow cytometry (FACS) of
relevant surface markers, including CD14, CD16, CD80,
CD83, CD86, and MHC II. FACS analysis was per-
formed on DC infected with vital L. innocua and
L. monocytogenes strain EGD. The data revealed that
both the DC population, with our in vitro culture pro-
tocol, were CD14, CD16+, CD80+, and they strongly
expressed CD83, CD86, and MHC II (Fig. 2b). Further
tests were performed with DC infected with L. monocyt-
ogenes strain RIII and with DC coincubated with heat-
inactivated bacteria (data not shown). All tests indicated
that challenge with Listeria did not impair expression
levels of the surface molecules tested in this study.
Intracellular processing and surface presentation
of Listeria antigens
We further analyzed the intracellular processing of
Listeria by confocal laser-scanning microscopy (Fig. 3).
Using a polyclonal rabbit anti-Listeria Ab combined
with a mouse mAb directed against a late phagosomal
marker, the lysosomal-associated membrane protein
LAMP-1, L. innocua were found with and without
colocalization with LAMP-1, indicating presence of
the Listeria inside and outside the phagolysosomes of
172
the DC (Fig. 3, top row) Listeria without colocalized
LAMP-1 might still be conﬁned to the endosomes.
Moreover, double immunostaining of the DC by the
anti-Listeria-Ab combined with a monoclonal Ab di-
rected against human MHC class II (HLA-DR, DP, and
DQ) displayed Listeria located within the phagolyso-
somes colocalized with MHC II molecules (Fig. 3,
middle row). We further used the same combination of
Abs with a modiﬁed permeabilization protocol (Triton)
where the MHC II molecules at the cell surface remained
intact. Thus, we were able to show that DC harboring L.
innocua expressed MHC II molecules also at the cell
surface surrounded by other PBMC, presumably T cells
(Fig. 3, bottom row). Similar results were obtained with
L. monocytogenes strain EGD (data not shown).
Phenotypic characterization of human T cells primed
with autologous L. innocua-harboring DC
Distinct Listeria-speciﬁc T-cell populations were primed
from freshly isolated human PBMC obtained from three
healthy donors using autologous DC. For that purpose,
DC were cocultured with L. innocua at MOI of 200 and
used for weekly restimulation of PBMC to prime in vitro
Listeria-speciﬁc T cells. Phenotypic characterization by
ﬂow cytometry of the PBMC before challenge indicated
that the population consisted of about 35% natural
killer (NK) cells (CD3, CD16+, CD56+) and 65% T
lymphocytes (CD3+). After 2 weeks in culture, the
PBMC-derived population consisted of approximately
85% CD3+ T lymphocytes and 15% NK cells. After
3 weeks, NK cells had completely disappeared, and an
approximately 100% CD3+ T lymphocyte population
(ﬁrst donor: CD4+: 90%, CD8+: 10%; second donor:
CD4+: 80%, CD8+: 20%; third donor: CD4+: 30%,
CD8+: 60%) was obtained. At that time point, speci-
ﬁcity of the T lymphocytes from either donor was tested.
CD4+ T cells primed in vitro by L. innocua-challenged
DC recognize Listeria-derived antigens presented by
autologous DC
First, we tested whether the T lymphocytes primed in
vitro in the presence of autologous L. innocua-chal-
lenged DC were capable of recognizing Listeria-infected
DC. Furthermore, we were interested in the stimulatory
capacity of the infected DC. For that purpose, the
L. innocua-primed T cells were incubated in the presence
of DC challenged with L. innocua (Fig. 4).
The L. innocua-primed T lymphocytes showed a sig-
niﬁcant proliferative response to DC infected with
L. innocua (column 2; P<0.0001), which was compar-
able to that with untreated DC in the presence of an
unspeciﬁc mitogenic stimulus (anti-CD3 mAb; column
5). For negative control, we co-incubated the T cells with
untreated DC (column 4), which did not signiﬁcantly
increase the basal proliferative activity of the T cells
(column 6). The relatively high background activity of
the T cells was probably due to our culture protocol
where the T cells were primed by weekly restimulation
with L. innocua-harboring DC from which residual
stimulation might have arisen. Similar data were
obtained from the other two donors (data not shown).
As further controls, we also tested naı¨ve autologous
Fig. 1 Entry and intracellular localization of Listeria innocua and
L. monocytogenes strains in dendritic cells (DC) visualized with
transmission electron microscopy (TEM). Top: L. innocua enter DC
by a zipper-like uptake. N Nucleus. Middle: L. monocytogenes
strain EGD within vacuoles (arrowheads) and in the cytosol with
beginning of actin polymerization (arrow). Bottom p60-reduced
L. monocytogenes strain RIII revealing typical chain formation.
Bars indicate 500 nm
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PBMC, which did not respond to the presence of Lis-
teria-harboring DC (column 8) and tetanus toxin-spe-
ciﬁc T cells, which also did not respond to L. innocua-
challenged DC (donor 3; data not shown). As a culture
media control, T lymphocytes were cocultured with
untreated DC in the presence of tryptic soy broth and
gentamicin. No proliferative T-cell activity was induced
(data not shown).
We further tested whether antigen presentation to the
CD4+ T cells was mediated via MHC II molecules, as
indicated by the morphologic studies. For that purpose,
we used the mAb directed against human MHC II mole-
cules (HLA-DR, DP, and DQ) to block antigen presen-
tation by the DC. The proliferative response of the
L. innocua-primedTcells in thepresence ofDCchallenged
with L. innocua could be signiﬁcantly (column 3;
P<0.0001) inhibited with the MHC II mAb. On the
contrary, treatment of T lymphocytes with the anti-MHC
II mAb did not impair their proliferative activity (column
7). The results conﬁrmMHC II-mediated speciﬁc antigen
presentation already shownwith ﬂuorescencemicroscopy
(Fig. 3). Similar results were also obtained using T cells
obtained from donor 2 (data not shown).
Furthermore, we were interested to see if the
L. innocua-primed T lymphocytes were also capable of
recognizing the pathogenic L. monocytogenes (Fig. 5).
We wanted to suppress the escape of bacteria from the
phagosomes and thus support presentation of bacterial
antigens by DC on MHC II molecules. For that pur-
pose, we inactivated, prior to infection, the virulent
L. monocytogenes using gentamicin or heat treatment.
Eﬃcient deactivation of the Listeria was controlled in an
overnight culture, where no growth was detected.
The DC harboring gentamicin-inactivated L. mono-
cytogenes strain EGD were able to induce a signiﬁcant
proliferative activity of the L. innocua-primed T cells
(Fig. 5a, column 2; P<0.0001) compared with untreated
DC (column 4), indicating cross-reactive antigen re-
cognition between the Listeria species mediated by DC.
Similar results were obtained with heat-inactivated
L. monocytogenes (data not shown). Further, we ana-
lyzed additional antigens possibly involved in cross-
reactivity among L. innocua and L. monocytogenes. For
that purpose, T lymphocytes were exposed to autolo-
gous DC co-incubated with the gentamicin-deactivated
p60-reduced L. monocytogenes rough mutant strain
RIII. p60 is a housekeeping protein constitutively
expressed also by L. innocua and lacking all PrfA-regu-
lated virulence factors such as internalin and listerioly-
sin, which L. monocytogenes possesses (compare
Table 1). Also, DC harboring L. monocytogenes strain
RIII were capable of a potent stimulation of the
L. innocua-primed T cells (column 2; P=0.0002) com-
pared with untreated DC (column 4).
Also with the L. monocytogenes strains, the prolifer-
ative response could be signiﬁcantly reduced (EGD:
Fig. 5a, column 3; P<0.0001; RIII: Fig. 5b, column 3;
P=0.0003) with the anti-MHC II mAb to the baseline
proliferation level of the T cells.
Discussion
Listeria is a well-established model for studying
the immune reaction against intracellular bacteria. It
Fig. 2 Dendritic cell (DC) viability and immunogenic capacity
after Listeria infection. DC were challenged with Listeria mono-
cytogenes strain EGD and L. innocua at MOI 200 and analyzed
after 16 h of further cultivation. a Quantiﬁcation of ﬂuorescence
released by living cells in (%, y axis) was according to the formula
described in Materials and methods. Grey column: DC infected with
L. monocytogenes strain EGD; white column: DC infected with
L. innocua (graph shows mean ± standard deviation = error bars).
Representative from three independent experiments. b Cytoﬂuoro-
metric measurement of surface markers relevant for antigen
presentation (MHC II, CD83, CD86). Black curve: isotype control;
white curve: DC infected with L. monocytogenes or L. innocua
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consists of a large family of pathogenic and apathogenic
species and is well characterized concerning genetic dif-
ferences (Cabanes et al. 2002; Glaser et al. 2001). For
these reasons, we chose Listeria as a model for the
analysis: how DC act after challenge with intracellular
pathogens. In our study, both the pathogenic and
apathogenic Listeria species were phagocytosed by
DC via the already described zipper-like uptake (see
Kolb-Ma¨urer et al. 2000), transferred into endosomes
(Fig. 1), processed in phagolysosomes (Fig. 3), and
presented on MHC II molecules (Figs. 2, 3, 4, 5). Our
ﬁndings conﬁrm recent studies that showed DC to be
highly tolerant toward infection with Listeria and
unimpaired concerning antigen presentation (Paschen
et al. 2000). In our experiments, at MOI of 200, DC
revealed a strong immunogenic capacity and ability to
eﬃciently prime in vitro speciﬁc T cells (Figs. 2, 3, 4, 5).
This is in contrast to the results obtained in a mouse
spleen DC cell line (CB1), which showed apoptosis of
DC after L. monocytogenes infection (MOI 100, Guz-
man et al. 1995). Nevertheless, in a recent study in
BALB/c mice, the cytokine gene expression of gastric
tissue was functionally not impaired after L. monocyt-
ogenes infection (Park et al. 2004). For IL-12 and IL-18,
produced by L. monocytogenes-infected human DC (see:
Kolb-Ma¨urer et al. 2003a), gene expression was not
reduced in the infected animals; on the contrary, it
displayed a parallel increase with progressing
Fig. 3 Intracellular processing and presentation of Listeria innocua
by dendritic cells (DC) examined with confocal laser-scanning
microscopy. Top row: polyclonal antibody (Ab) directed against
Listeria (red) detected with and without colocalization with
monoclonal antibody (mAb) against LAMP-1 (green), indicating
presence of bacteria within and outside the phagolysosomes.
Middle row: polyclonal Ab directed against Listeria (red) colocal-
ized with intracellular MHC II compartment stained with mAb
(green). Bottom row: DC harboring L. innocua (red) expressing
MHC II molecules stained with mAb (green) at the cell surface.
DAPI-staining (blue) also shows nuclei of T cells (arrowhead),
which are MHC-II-negative and do not contain L. innocua. Bars
indicate 7 lm
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histopathological lesions (Park et al. 2004), which might
indicate a similar active synthesis in the mouse DC also.
The pathogenic L. monocytogenes disposes over an
apathogenic relative species, the L. innocua (Vasquez-
Boland et al. 2001). Cross-reactivity between both the
Listeria species mediated by opsonizing antibodies for
enhanced phagocytosis has already been postulated
(Kolb-Ma¨urer et al. 2001). However, a link between the
humoral immune reaction towards L. monocytogenes in-
duced by challenge with L. innocua and a cellular immune
response has not been shown to date. The model of cross-
reactivity of T lymphocytes primed using DC infected
with an avirulent relative species, such as L. innocua, and
recognition of common antigens on pathogenic relative
species, such as L. monocytogenes, may contribute to a
better understanding of environmentally provided pro-
tection against obligate or facultative intracellularly
growing species (Kolb-Ma¨urer et al. 2001, 2003b).
In our in vitro study, we were able to prime speciﬁc T
cells by the use of DC infected with avirulent L. innocua.
Antigen presentation by the DC led to eﬃcient T-cell
priming of naı¨ve PBMC and also to successful recogni-
tion of Listerial antigens by the T cells that could be
blocked with an anti-MHC II Ab (Figs. 4, 5). The L.
innocua-primed T cells were also capable of recognizing
the pathogenic L. monocytogenes strain EGD when
presented by DC, indicating successful cross-priming for
both species (Fig. 5).
The predominant common antigen between the Lis-
teria species is suggested to be the p60 protein, which is
also constitutively found in L. innocua, in contrast to the
PrfA-regulated virulence factors of L. monocytogenes,
such as listeriolysin. The p60 protein, encoded by the iap
gene, acts as an essential tool for cell viability and is
required in a late step of cell division. It is the major
extracellular protein of L. monocytogenes that contrib-
utes to its uptake into ﬁbroblasts and macrophages
(Kuhn and Goebel 1989; Bubert et al. 1992). In mice,
listeriolysin and p60 protein from L. monocytogenes have
been detected as main targets for CD4+ and CD8+ T
cells (Brunt et al. 1990; Saﬂey et al. 1991; Harty and
Pamer 1995; Harty et al. 1996; Geginat et al. 1999;
Sˇkoberne and Geginat 2002). This is the reason we chose
to additionally test the p60-reduced L. monocytogenes
strain RIII (Bubert et al. 1992) where we found a strong
cross-reactivity in the strain RIII, which again could be
signiﬁcantly blocked with a anti-MHC II mAb (Fig. 5),
indicating speciﬁc bacterial antigen recognition
(Kapsenberg 2003). However, it has to be considered that
p60 synthesis is not completely abolished in this
L. monocytogenes rough mutant strain but just greatly
reduced (Bubert et al. 1992; Rowan et al. 2000). Thus,
further studies are necessary to determine the possible
antigens mediating cross-reactivity between L. innocua
and L. monocytogenes. Common potential antigenic
components of both Listeria species are under debate
since there are only 68 genes encoding putative lipopro-
teins identiﬁed in L. monocytogenes, of which only six
are absent in the L. innocua genome (Cabanes et al.
2002). The importance of bacterial lipoproteins for
DC-mediated immune reaction has been recently shown
in studies using Borrelia burgdorferi (Beermann et al.
2000).
From our results, we conclude that DC infected with
nonpathogenic intracellular bacteria are able to survive
infection, process Listerial antigens for presentation on
MHC II molecules, and eﬃciently prime naı¨ve PBMC to
speciﬁc, mainly CD4+, T cells. These T cells may then
even be suitable tools for the recognition of antigens of
virulent relative bacteria species, which might provide an
interesting approach for further research on the cellular
immune response to bacteria. Recombinant L. mono-
cytogenes is, in addition, an attractive tool as a vaccine
vector, e.g., against human immunodeﬁciency virus
(HIV). In a recent study, it could be demonstrated that
oral immunization with recombinant L. monocytogenes
controls virus load after vaginal challenge with feline
immunodeﬁciency virus (FIV) (Stevens et al. 2004).
Thus, further knowledge on Listeria’s fate within DC
Fig. 4 Proliferative response of Listeria innocua-primed T cells
(donor 1) after 3 weeks in culture (predominantly CD4+) exposed
to autologous dendritic cells (DC) challenged with L. innocua (Li).
Column 1: L. innocua-challenged DC. Column 2: L. innocua-primed
T cells co-incubated with L. innocua-challenged DC. Column 3:
Reaction from (column 2) blocked with anti-human MHC II
monoclonal antibodies (mAb). Column 4: L. innocua-primed T cells
co-incubated with untreated DC. Column 5: L. innocua-primed T
cells cocultivated with untreated DC in the presence of anti-CD3
mAb as unspeciﬁc mitogenic stimulus. Column 6: L. innocua-
primed T cells. Column 7: L. innocua-primed T cells treated with
anti-MHC II mAb. Column 8: Naı¨ve human peripheral blood
mononuclear cells (PBMC) cocultured with L. innocua-challenged
DC. 3H-thymidine incorporation assay. CPM counts per minute.
Means (± standard deviation, error bars) were calculated from
triplicates
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might bring new insights into the processing of antigens
in DC, in general.
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